Median Technologies Receives FDA 510(k) Clearance for eyonis® LCS, the First AI Tech-Based Detection and Diagnosis Device for Lung Cancer Screening Median Technologies developer of eyonis®, a suite of artificial intelligence…
Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial Intelligence Evinova today announced that Bristol Myers Squibb has signed an agreement to optimize clinical trials…
Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS) Genentech, a member of the Roche Group announced today…
Roche’s fenebrutinib becomes the first investigational therapy in over a decade to slow disability progression in primary progressive multiple sclerosis (PPMS) Roche announced today new late-breaking data from the Phase…
Dr. Joseph Chang Launches Update to Bestselling Book “The Aging Myth” With 15 More Years of Breakthrough Research on Cellular Wellness Nu Skin Enterprises Inc. today announced the relaunch of…
Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium Johnson & Johnson today announced 12-month pilot-phase data from the OMNY-AF study, evaluating the investigational…
Rapid Medical’s DISTALS Trial Overwhelmingly Positive, Demonstrating Superior Reperfusion with TIGERTRIEVER™ 13 in Medium Vessel Stroke Rapid Medical™, a leading developer of active endovascular devices, today announced late-breaking results from…
A Legacy of Brighter Smiles: Celebrating 24 Years of the Give Kids A Smile Program The American Dental Association Foundation (ADAF) is officially kicking off Give Kids A Smile® (GKAS) 2026…
Applied Medical Prevails in Antitrust Jury Trial Against Medtronic Applied Medical announced today a significant legal victory that should help open the healthcare market to innovation and lower costs. A…
National Supplemental Screening Program Celebrates 20 Years of Service; Eligible Individuals Encouraged to Participate The U.S. Department of Energy (DOE) National Supplemental Screening Program (NSSP), managed by ORAU, is celebrating…
Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has…
Biotech Showcase™ 2026 Brought Early-Stage Biotech Innovation to the Forefront During JPM Healthcare Week As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year, the event continued to distinguish itself as a leading hub…